0003-4160 : Augtyro 160 mg Oral Capsule


NDC: 0003-4160
Labeler: E.r. Squibb & Sons, L.L.C.
Product Type: Human Prescription Drug
Drug Name:  Augtyro
Dosage Form: Oral Capsule
Application #: NDA218213
Rev. Date: 


NDC Package Codes:

  • 0003-4160-14: 14 CAPSULE IN 1 BOTTLE (0003‑4160‑14)
  • 0003-4160-60: 60 CAPSULE IN 1 BOTTLE (0003‑4160‑60)

Active Ingredients:

  • Repotrectinib

Dosage Strength:

  • 160 mg

Pharmaceutical Classes:

  • Cytochrome P450 3A4 Inducers [MoA]
  • Kinase Inhibitor [EPC]
  • Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]
  • Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]
  • Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]
  • Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0003-4040 Augtyro 40 mg Oral Capsule by E.r. Squibb & Sons, L.L.C.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0003-4160 QR Code

< Prev: 0003-4040Next: 0003-4214 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.